Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-064-1 | CAS number: 50-78-2
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Before BPL and guidelines
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Principles of method if other than guideline:
- ASA: in an isotonic phosphate buffer at pH7. The volume injected in each case was 0.1 ml. The 5 injections were administered on Days 0, 2, 5, 8 and 12.On Day 16, the contact solution was applied. Each time, we used a mixture of acetone-almond oil in a 1:1 ratio (V:V).
- GLP compliance:
- no
- Type of study:
- guinea pig maximisation test
- Species:
- guinea pig
- Strain:
- not specified
- Sex:
- not specified
- Route:
- intradermal
- Concentration / amount:
- 200 and 100 mg/ml
- Route:
- epicutaneous, occlusive
- Concentration / amount:
- 200 and 100 mg/ml
- No. of animals per dose:
- 10
- Positive control substance(s):
- yes
- Remarks:
- acetylsalicylic acid anhydride (ASAN)
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 200 mg/mL
- No. with + reactions:
- 0
- Total no. in group:
- 0
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 200 mg/mL. No with. + reactions: 0.0. Total no. in groups: 0.0.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- ASA is not sensitizing in a guinea pig test comparable to maximisation.
- Executive summary:
ASA tested at high doses ( induction at 200 and 100 mg/ml intracutaneous) in guinea pigs, with a normal amount ( 0.01%) od the sensitising impurity ASAN, was totally negative in ths assay.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
ASA being not a skin sensitiser is also considered as a non respiratory sensitiser.
Migrated from Short description of key information:
ASA was not sensitising in the guinea pig and compared to an impurity (ASAN: acetyl salicylic anhydride) which is sensitising
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
- Migrated from Short description of key information:
ASA being not a skin sensitiser is also considered as a non respiratory sensitiser.
Justification for classification or non-classification
Not a sensitizer
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
